Treatment of vaginal infections: candidiasis, bacterial vaginosis, and trichomoniasis.
OBJECTIVE
To describe the signs and symptoms of and recommend treatments for Candida vulvovaginitis, bacterial vaginosis, and Trichomonas vaginitis.


METHODS
Current clinical literature.


RESULTS
Patients with candidal vulvovaginitis often present with itching, burning, white discharge, vulvar or vaginal erythema, painful intercourse, and stinging on urination. It is treated with oral or topical antifungal agents. Bacterial vaginosis is characterized by a musty or fishy vaginal odor and a thin, white vaginal discharge. It is treated with oral or topical metronidazole or clindamycin. Patients with trichomoniasis usually complain of profuse, yellow-green discharge and vaginal or vulvar irritation. The standard treatment is a single 2 gram dose of oral metronidazole for both the patient and sexual partners.


CONCLUSIONS
Given the potential adverse effects of the drugs used to treat these conditions, pharmacists are in a unique position to recommend appropriate therapies and to refer patients to other health care providers as needed.
Ries
A J
AJ
Department of Defense Pharmacoeconomic Center, College of Pharmacy, University of Texas at Austin 78234-6190, USA. Andrea_Ries@smtplink.hcssa.amedd.army.mil
D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000994:Antitrichomonal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D004347:Drug Interactions; D005260:Female; D006801:Humans; D014247:Trichomonas Vaginitis / Q000188:drug therapy* / Q000453:epidemiology; D016585:Vaginosis, Bacterial / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology
D000935:Antifungal Agents; D000994:Antitrichomonal Agents